Despite its limitations, this study is the first comprehensive analysis of ERBB2 fusions in a larger group of Chinese patients with various carcinomas, it has extended our understanding of ERBB2 fusions in solid tumors significantly and may provide more inspiration in the upcoming clinical trials. This evidence concerns the gene ERBB2 and carcinoma.